Create a forecasted balance sheet for Fiscal Year 2020 using the data provided.

Following is the balance sheet for Medtronic PLC for FY2019 ended April 26, 2019.

Consolidated Balance Sheet ($ millions)	April 26, 2019
Current assets
Cash and cash equivalents	$ 4,393
Investments	5,455
Accounts receivable, net	6,222
Inventories, net	3,753
Other current assets	2,144
Total current assets	21,967
Property, plant, and equipment, net	4,675
Goodwill	39,959
Other intangible assets, net	20,560
Tax assets	1,519
Other assets	1,014
Total assets	$89,694
Current liabilities
Current debt obligations	$ 838
Accounts payable	1,953
Accrued compensation	2,189
Accrued income taxes	567
Other accrued expenses	2,925
Total current liabilities	8,472
Long-term debt	24,486
Accrued compensation and retirement benefits	1,651
Accrued income taxes	2,838
Deferred tax liabilities	1,278
Other liabilities	757
Total liabilities	39,482
Shareholders' equity
Ordinary shares	0
Additional paid-in capital	26,532
Retained earnings	26,270
Accumulated other comprehensive loss	(2,711)
Total shareholders' equity	50,091
Noncontrolling interests	121
Total equity	50,212
Total liabilities and equity	$89,694

Use the following assumptions to forecast the company's balance sheet for FY2020.

Forecasted FY2020 net income	$4,927 million
Forecasted FY2020 net sales	$33,002 million
Investments	No change
Accounts receivable, less allowance	20.4% of net sales
Inventories, net	12.3% of net sales
Other current assets	7% of net sales
Goodwill	No change
Tax assets	5% of net sales
Other assets	3.3% of net sales
Accounts payable	6.4% of net sales
Accrued compensation (current liability)	7.2% of net sales
Accrued compensation and retirement benefits (noncurrent liability)	No change
Accrued income taxes (current liability)	1.9% of net sales
Other accrued expenses	9.6% of net sales
Accrued income taxes (noncurrent liability)	9.3% of net sales
Deferred tax liabilities	4.2% of net sales
Other liabilities	2.5% of net sales
Ordinary shares	No change
Accumulated other comprehensive loss	No change
Net income attributable to noncontrolling interest	$19 million
Dividends in FY2020	$2,853 million
CAPEX	3.7% of net sales
Depreciation expense in FY2020	$950 million
Amortization expense in FY2020	$1,914 million
Debt due in FY2020	$838 million
Debt due in FY2021	$2,058 million